European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent

Portola Pharmaceuticals (PTLA) PT Raised to $50 at Citi

March 4, 2019 6:58 AM EST

Citi analyst Yigal Nochomovitz raised the price target on Portola Pharmaceuticals (NASDAQ: PTLA) to $50.00 (from $49.00) while maintaining a Buy rating as the company launches Andexxa. Nochomovitz is being executed well under the new CEOs leadership and should be owned as path to Andexxa growth is... More